TriStar Health Partners

TVA Medical, Inc. is a medical device company based in Austin, Texas, focused on developing catheter-based solutions for end-stage renal disease and peripheral vascular diseases. Founded in 2009, the company specializes in innovative, minimally invasive therapies, notably through its everlinQ endoAVF system. This system facilitates the creation of an arteriovenous fistula using an endovascular approach, allowing for hemodialysis in patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. TVA Medical operates as a subsidiary of Becton, Dickinson and Company and has received funding from Santé Ventures.

MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.

Evermind, Inc. offers innovative solutions that allow users to monitor their home appliances, providing reassurance for individuals living alone and their caregivers. The company's flagship product, Evermind, sends notifications via text or email when appliances such as coffee makers, TVs, and lamps are turned on or off, effectively tracking daily activities without invading privacy. This system serves as a modern check-in mechanism, enabling users to maintain their independence while ensuring that loved ones can stay informed about their well-being. Founded in 2012 and headquartered in Nashville, Tennessee, Evermind aims to replicate the supportive community dynamics of the past by utilizing technology to observe daily rituals, thereby enhancing peace of mind for both users and their families.

Advanced Catheter Therapies, an early stage research and development medical device company, has a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. ACT is developing a revolutionary device for restenosis (re-blockage of blood vessels) and as well as catheters for endovascular debulking (clearing of blocked blood vessels).

MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Preferral is an referral management system. Preferral allows primary care practices save time on referrals, and specialists to increase and analyze their patient referrals. With Preferral's online referral forms, practices can add an easy-to-use referral form to their website. Patients can get referral appointments instantly while administrative costs are reduced and communications streamlined. Preferral doesn’t require any complicated integrations with the EHR. Preferral allows practices to uncover valuable insights about their referral relationships and improve marketing efforts. Preferral was founded by Jon Gautsch in 2013 and is headquartered in Nashville, Tennessee.

InvisionHeart is a company focused on enhancing cardiac care through its innovative hardware and software system designed to capture and manage cardiac data. Originating from research conducted by physicians and engineers at Vanderbilt University, the technology addresses real-world clinical challenges faced by heart patients. InvisionHeart offers a mobile electrocardiograph system that allows a network of healthcare professionals, including physicians, nurses, and technicians, to securely access and annotate patient electrocardiogram tracings. The company's leadership, consisting of experienced professionals in both software and hardware development, along with a strong clinical advisory team, is dedicated to improving the care of heart patients in diverse environments.

Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Bjond Inc. operates in the technology sector. The company was founded in 2012 and is based in Columbus, Ohio. Bjönd is automated workflow, real-time decision support and behavior change software that consumers and businesses use to change outcomes and lives in any industry . . . in any situation. Bjönd is designed to enable anyone - even those with little or no technical skills - to build interactive content and automated, expert workflows for any subject.

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible and actionable data for population health management. The company's platform enables healthcare organizations to search, filter, and visualize patient information, taking into account social and environmental factors that influence health outcomes. By uncovering trends and patterns within patient populations, Quire supports predictive modeling, provider evaluation, and diagnostic coding. Additionally, the system helps healthcare providers identify and manage high-risk patients, strategize healthcare spending, and optimize resource allocation. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Preferral is an referral management system. Preferral allows primary care practices save time on referrals, and specialists to increase and analyze their patient referrals. With Preferral's online referral forms, practices can add an easy-to-use referral form to their website. Patients can get referral appointments instantly while administrative costs are reduced and communications streamlined. Preferral doesn’t require any complicated integrations with the EHR. Preferral allows practices to uncover valuable insights about their referral relationships and improve marketing efforts. Preferral was founded by Jon Gautsch in 2013 and is headquartered in Nashville, Tennessee.

VenX Medical LLC is a medical device company based in Nashville, Tennessee, specializing in the treatment of varicose veins associated with venous insufficiency. Founded in 2009, the company develops innovative devices utilizing nanophlebectomy technology for the treatment of spider and reticular veins. Its primary offerings include VenX Reach, a minimally invasive disposable device designed for horizontal phlebectomy, and a handheld device that disrupts the vein structure to promote coagulation. These devices can be used independently or as adjuncts to other vein therapies such as endovenous ablation and sclerotherapy. Through its advanced medical technology, VenX Medical aims to provide effective solutions for patients suffering from venous disorders.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

TVA Medical, Inc. is a medical device company based in Austin, Texas, focused on developing catheter-based solutions for end-stage renal disease and peripheral vascular diseases. Founded in 2009, the company specializes in innovative, minimally invasive therapies, notably through its everlinQ endoAVF system. This system facilitates the creation of an arteriovenous fistula using an endovascular approach, allowing for hemodialysis in patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. TVA Medical operates as a subsidiary of Becton, Dickinson and Company and has received funding from Santé Ventures.

Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible and actionable data for population health management. The company's platform enables healthcare organizations to search, filter, and visualize patient information, taking into account social and environmental factors that influence health outcomes. By uncovering trends and patterns within patient populations, Quire supports predictive modeling, provider evaluation, and diagnostic coding. Additionally, the system helps healthcare providers identify and manage high-risk patients, strategize healthcare spending, and optimize resource allocation. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Evermind, Inc. offers innovative solutions that allow users to monitor their home appliances, providing reassurance for individuals living alone and their caregivers. The company's flagship product, Evermind, sends notifications via text or email when appliances such as coffee makers, TVs, and lamps are turned on or off, effectively tracking daily activities without invading privacy. This system serves as a modern check-in mechanism, enabling users to maintain their independence while ensuring that loved ones can stay informed about their well-being. Founded in 2012 and headquartered in Nashville, Tennessee, Evermind aims to replicate the supportive community dynamics of the past by utilizing technology to observe daily rituals, thereby enhancing peace of mind for both users and their families.

Cerebrotech Medical Systems, Inc. specializes in the development of non-invasive monitoring technology aimed at patients recovering from strokes or traumatic brain injuries. The company's flagship product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which are critical indicators in various neurological conditions. By continuously monitoring brain fluids, the device allows healthcare providers to identify potential increases in intracranial pressure before they escalate, enabling timely medical intervention to prevent further brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes in neurological assessments and treatment.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diabetes Care Group, Inc. is a provider of specialized clinical care services for individuals with diabetes, based in Jackson, Mississippi. Founded in 1986, the company focuses on delivering an interdisciplinary model that integrates medical management, patient education, and behavioral modification. Their services include personalized counseling, diet and nutrition guidance, blood glucose monitoring, and point-of-care laboratory testing, all aimed at enhancing patient self-management and clinical outcomes. With a commitment to reducing the overall medical and social costs associated with diabetes, Diabetes Care Group employs a team of experienced professionals, including board-certified physicians, registered nurse educators, and registered dieticians. This integrated approach is backed by over ten years of research and clinical experience, demonstrating significant improvements in health outcomes for patients facing the challenges of diabetes.

Cerebrotech Medical Systems, Inc. specializes in the development of non-invasive monitoring technology aimed at patients recovering from strokes or traumatic brain injuries. The company's flagship product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which are critical indicators in various neurological conditions. By continuously monitoring brain fluids, the device allows healthcare providers to identify potential increases in intracranial pressure before they escalate, enabling timely medical intervention to prevent further brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes in neurological assessments and treatment.

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Diabetes Care Group, Inc. is a provider of specialized clinical care services for individuals with diabetes, based in Jackson, Mississippi. Founded in 1986, the company focuses on delivering an interdisciplinary model that integrates medical management, patient education, and behavioral modification. Their services include personalized counseling, diet and nutrition guidance, blood glucose monitoring, and point-of-care laboratory testing, all aimed at enhancing patient self-management and clinical outcomes. With a commitment to reducing the overall medical and social costs associated with diabetes, Diabetes Care Group employs a team of experienced professionals, including board-certified physicians, registered nurse educators, and registered dieticians. This integrated approach is backed by over ten years of research and clinical experience, demonstrating significant improvements in health outcomes for patients facing the challenges of diabetes.

ONFocus Healthcare, originally established in 1985 as m21partners, transitioned in 2008 to focus on providing business execution software solutions specifically for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance the operational effectiveness of healthcare organizations. Their flagship product, onFocus epm™, facilitates improved patient care by enabling hospitals to track and manage plans, metrics, and resources more efficiently. By offering both software and advisory services, ONFocus Healthcare aims to boost the execution success and performance of healthcare providers by at least 20%, ultimately ensuring patients receive better, faster, and more cost-effective care.

Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

ONFocus Healthcare, originally established in 1985 as m21partners, transitioned in 2008 to focus on providing business execution software solutions specifically for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance the operational effectiveness of healthcare organizations. Their flagship product, onFocus epm™, facilitates improved patient care by enabling hospitals to track and manage plans, metrics, and resources more efficiently. By offering both software and advisory services, ONFocus Healthcare aims to boost the execution success and performance of healthcare providers by at least 20%, ultimately ensuring patients receive better, faster, and more cost-effective care.